[1] LEES RA, HENDRY BAK, BROOMFIELD N, et al. Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items. Int J Geriatr Psychiatry. 2017;32(10):1072-1078.
[2] HILAL S, XU X, IKRAM MK, et al. Intracranial stenosis in cognitive impairment and dementia. J Cereb Blood Flow Metab. 2017;37(6):2262-2269.
[3] PISCOPO P, LACORTE E, FELIGIONI M, et al. MicroRNAs and mild cognitive impairment: a systematic review. Ageing Res Rev. 2019;50:131-141.
[4] HANSEN KF, KARELINA K, SAKAMOTO K, et al. MiRNA-132: a dynamic regulator of cognitive capacity. Brain Struct Funct. 2013;218(3):817-831.
[5] HUANG S, ZHAO J, HUANG D, et al. Serum miR-132 is a risk marker of post-stroke cognitive impairment. Neurosci Lett. 2016;615:102-106.
[6] YANG FW, WANG H, WANG C, et al. Upregulation of acetylcholinesterase caused by downregulation of microRNA-132 is responsible for the development of dementia after ischemic stroke. J Cell Biochem. 2020; 121(1):135-141.
[7] 徐珊珊,曾友华,包烨华.针灸通督法联合黄连温胆汤对脑卒中患者外周血miR-132、miR-134的影响[J].中国现代医生,2019,57(24):137-140, 144.
[8] STARY CM, SUN X, OUYANG Y, et al. miR-29a differentially regulates cell survival in astrocytes from cornu ammonis 1 and dentate gyrus by targeting VDAC1. Mitochondrion. 2016;30:248-254.
[9] RAGUSA M, BOSCO P, TAMBURELLO L, et al. miRNAs plasma profiles in vascular dementia: biomolecular data and biomedical implications. Front Cell Neurosci. 2016;10:51.
[10] BARBAGALLO C, MOSTILE G, BAGLIERI G, et al. Specific signatures of serum mirnas as potential biomarkers to discriminate clinically similar neurodegenerative and vascular-related diseases. Cell Mol Neurobiol. 2019; 40(4):531-546
[11] ZHENG Y, WANG L, CHEN M, et al. Upregulation of miR-130b protects against cerebral ischemic injury by targeting water channel protein aquaporin 4 (AQP4). Am J Transl Res. 2017;9(7):3452-3461.
[12] WANG P, LIANG X, LU Y, et al. MicroRNA-93 downregulation ameliorates cerebral ischemic injury through the Nrf2/HO-1 defense pathway. Neurochem Res. 2016;41(10):2627-2635.
[13] 周凡萍,人血清microRNAs作为脑卒中后认知功能障碍生物标志物的研究[D].福州:福建中医药大学,2018.
[14] 黄墩兵,谷诗浓,王振杰,等.miR-93-5p联合BDNF蛋白检测卒中后认知功能障碍的诊断价值[J].按摩与康复医学,2019,10(9):44-47.
[15] DONG H, LI J, HUANG L, et al. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer’s Disease. Dis Markers. 2015; 2015:625659.
[16] DAS S, FERLITO M, KENT OA, et al. Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res. 2012;110(12):1596-1603.
[17] 张仕娟,刘月华,李乃坤,等.急性脑梗死患者血清miR-181c水平与认知功能受损的关系[J].山东医药,2016,56(38):90-92.
[18] 闫小菊,张羽,李勇,等.血清微小RNA-181c、甲基乙二醛和25羟基维生素D_3水平在评估老年高血压患者发生认知功能障碍中的价值[J].中华高血压杂志,2019,27(12):1137-1142.
[19] CHEN YL SHEN CK. Modulation of mGluR-dependent MAP1B translation and AMPA receptor endocytosis by microRNA miR-146a-5p. J Neurosci. 2013;33(21):9013-9020.
[20] 董瑞,许鑫,陆雅媛,等.术后认知功能障碍小鼠miR-146a表达的变化[J].临床麻醉学杂志,2017,33(10):1016-1020.
[21] MULLER M, KUIPERIJ HB, CLAASSEN JA, et al. MicroRNAs in Alzheimer’s disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging. 2014;35(1):152-158.
[22] MARCHEGIANI F, MATACCHIONE G, RAMINI D, et al. Diagnostic performance of new and classic CSF biomarkers in age-related dementias. Aging (Albany NY). 2019;11(8):2420-2429.
[23] YASMEEN S, KAUR S, MIRZA AH, et al. miRNA-27a-3p and miRNA-222-3p as Novel Modulators of Phosphodiesterase 3a (PDE3A) in Cerebral Microvascular Endothelial Cells. Mol Neurobiol. 2019;56(8):5304-5314.
[24] OUYANG Y, LI D, WANG H, et al. MiR-21-5p/dual-specificity phosphatase 8 signalling mediates the anti-inflammatory effect of haem oxygenase-1 in aged intracerebral haemorrhage rats. Aging Cell. 2019;18(6):e13022.
[25] 欧阳烨彤.miR-21-5p在自发性脑出血患者血清中的表达及其与预后关系的研究[D].南昌:南昌大学,2019.
[26] ZHOU J, ZHANG J. Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction. Mol Med Rep. 2014;10(2):971-976.
[27] SORENSEN SS, NYGAARD ABCHRISTENSEN T. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia - an exploratory study. Transl Neurodegener. 2016;5:6.
[28] 林洋,芮耀诚.脑缺血大鼠脑组织及血浆中microRNA-124a表达的变化[J].中国脑血管病杂志,2011,8(3):143-147.
[29] PONOMAREV ED, VEREMEYKO T, BARTENEVA N, et al. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med. 2011;17(1):64-70.
[30] SUN M, HOU X, REN G, et al. Dynamic changes in miR-124 levels in patients with acute cerebral infarction. Int J Neurosci. 2019;129(7):649-653.
[31] RAJASETHUPATHY P, FIUMARA F, SHERIDAN R, et al. Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron. 2009;63(6):803-817.
[32] MALMEVIK J, PETRI R, KNAUFF P, et al. Distinct cognitive effects and underlying transcriptome changes upon inhibition of individual miRNAs in hippocampal neurons. Sci Rep. 2016;6:19879.
[33] MIAO W, BAO T-H, HAN J-H, et al. Neuroprotection induced by post-conditioning following ischemia/reperfusion in mice is associated with altered microRNA expression. Mol Med Report. 2016;14(3):2582-2588.
[34] YANG TT, LIU CG, GAO SC, et al. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer’s Disease Biomarkers. Biomed Environ Sci. 2018;31(2):87-96.
[35] PRABHAKAR P, CHANDRA SRCHRISTOPHER R. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease. Age Ageing. 2017;46(5):861-864.
[36] MA W, FU Q, ZHANG Y, et al. A Single-Nucleotide Polymorphism in 3’-Untranslated Region of Endothelin-1 Reduces Risk of Dementia After Ischemic Stroke. Med Sci Monit. 2016;22:1368-1374.
[37] HU XL, WANG XX, ZHU YM, et al. MicroRNA-132 regulates total protein of Nav1.1 and Nav1.2 in the hippocampus and cortex of rat with chronic cerebral hypoperfusion. Behav Brain Res. 2019;366:118-125.
[38] OUYANG Y, LI D, WANG H, et al. MiR-21-5p/dual-specificity phosphatase 8 signalling mediates the anti-inflammatory effect of haem oxygenase-1 in aged intracerebral haemorrhage rats. Aging Cell. 2019;18(6):e13022.
[39] TOYAMA K, SPIN JM, DENG AC, et al. MicroRNA-Mediated Therapy Modulating Blood-Brain Barrier Disruption Improves Vascular Cognitive Impairment. Arterioscler Thromb Vasc Biol. 2018;38(6):1392-1406.
[40] VAN DEN BERG MMJ, KRAUSKOPF J, RAMAEKERS JG, et al. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol. 2020;185:101732.
[41] WANG Z, LU G, SZE J, et al. Plasma miR-124 Is a Promising Candidate Biomarker for Human Intracerebral Hemorrhage Stroke. Mol Neurobiol. 2018;55(7):5879-5888.
[42] TSAI PC, LIAO YC, WANG YS, et al. Serum microRNA-21 and microRNA-221 as potential biomarkers for cerebrovascular disease. J Vasc Res. 2013;50(4): 346-354. |